These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dexfenfluramine reduces cardiovascular risk factors. Bremer JM; Scott RS; Lintott CJ Int J Obes Relat Metab Disord; 1994 Apr; 18(4):199-205. PubMed ID: 8044193 [TBL] [Abstract][Full Text] [Related]
3. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women. Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090 [TBL] [Abstract][Full Text] [Related]
4. Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction. Brownell KD; Stunkard AJ Arch Intern Med; 1981 Aug; 141(9):1142-6. PubMed ID: 7259372 [TBL] [Abstract][Full Text] [Related]
5. [Modification of serum lipids, lipoproteins and apoproteins AI and B in patients with hyperlipidemia Type IIa and IIb using polyenylphosphatidylcholine]. Noseda G; Suvà F; Fragiacomo C Schweiz Med Wochenschr; 1985 Jul; 115(30):1064-70. PubMed ID: 4035328 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein profile in patients who survive a stroke. Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499 [TBL] [Abstract][Full Text] [Related]
7. Body fat distribution, plasma lipoproteins and the risk of coronary heart disease of male subjects. Barakat HA; Burton DS; Carpenter JW; Holbert D; Israel RG Int J Obes; 1988; 12(5):473-80. PubMed ID: 3235266 [TBL] [Abstract][Full Text] [Related]
8. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up. O'Connor HT; Richman RM; Steinbeck KS; Caterson ID Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494 [TBL] [Abstract][Full Text] [Related]
9. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study. Muls E; Kolanowski J; Scheen A; Van Gaal L; Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595 [TBL] [Abstract][Full Text] [Related]
10. [Effect of the PSMF diet on plasma lipids and lipoproteins in obese subjects]. Petrillo A; Chevaux F; Rohrer J; Darioli R Schweiz Med Wochenschr; 1984 Dec; 114(49):1837-41. PubMed ID: 6515380 [TBL] [Abstract][Full Text] [Related]
11. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894 [TBL] [Abstract][Full Text] [Related]
12. [Lipids, lipoproteins, arterial accidents and oral contraceptives]. Bakir R; Hilliquin P Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243 [TBL] [Abstract][Full Text] [Related]
13. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study. Ikewaki K; Noma K; Tohyama J; Kido T; Mochizuki S Int J Cardiol; 2005 Jun; 101(3):441-7. PubMed ID: 15907413 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, double-dummy, randomized, placebo-controlled trial to evaluate the effect of statin therapy on triglyceride levels in Mexican hypertriglyceridemic patients. Talavera JO; Martinez G; Cervantes JL; Marin JA; Rodriguez-Briones I; Gonzalez JG; Ocampo R; Sanchez-Mijangos H; Bernal-Rosales LP; Polanco A Curr Med Res Opin; 2013 Apr; 29(4):379-86. PubMed ID: 23323877 [TBL] [Abstract][Full Text] [Related]
15. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206 [TBL] [Abstract][Full Text] [Related]
16. Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults. Oelrich B; Dewell A; Gardner CD Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):350-7. PubMed ID: 21924882 [TBL] [Abstract][Full Text] [Related]
17. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. Phillipson BE; Rothrock DW; Connor WE; Harris WS; Illingworth DR N Engl J Med; 1985 May; 312(19):1210-6. PubMed ID: 3990714 [TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins. Tedeschi-Reiner E; Reiner Z; Sonicki Z Croat Med J; 2004 Jun; 45(3):333-7. PubMed ID: 15185429 [TBL] [Abstract][Full Text] [Related]
19. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
20. Consumption of a controlled low-fat diet containing olestra for 9 months improves health risk factors in conjunction with weight loss in obese men: the Ole' Study. Lovejoy JC; Bray GA; Lefevre M; Smith SR; Most MM; Denkins YM; Volaufova J; Rood JC; Eldridge AL; Peters JC; Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1242-9. PubMed ID: 14513073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]